nitroblue tetrazolium has been researched along with Di Guglielmo Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awaya, A; Honma, Y; Ishii, Y; Kakegawa, T; Kasukabe, T; Okabe-Kado, J; Yamamoto-Yamaguchi, Y | 1 |
| Hattori, M; Honma, Y; Hozumi, M; Makishima, M; Motoyoshi, K; Sampi, K | 1 |
2 other study(ies) available for nitroblue tetrazolium and Di Guglielmo Disease
| Article | Year |
|---|---|
Induction of differentiation of human myeloid leukemia cells by novel synthetic neurotrophic pyrimidine derivatives.
Topics: Calcitriol; Cell Differentiation; Cell Division; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Granulocytes; HL-60 Cells; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Mitogen-Activated Protein Kinases; Monocytes; Nitroblue Tetrazolium; Pyrimidines; Tretinoin; Tumor Cells, Cultured | 2001 |
Induction of differentiation of human leukemia cells by inhibitors of myosin light chain kinase.
Topics: Azepines; Cell Differentiation; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Promyelocytic, Acute; Muramidase; Myosin-Light-Chain Kinase; Naphthalenes; Nitroblue Tetrazolium; Oxidation-Reduction; Tumor Cells, Cultured | 1991 |